Formulation of pyrazinamide-loaded large porous particles for the pulmonary route: Avoiding crystal growth using excipients
Authors:
- Dinh-Duy PhamDPDinh-Duy Pham
- Elias FattalEFElias Fattal
- NourEddine GhermaniNGNourEddine Ghermani
- Nicolas GuiblinNGNicolas Guiblin
- Nicolas TsapisNTNicolas Tsapis
- 1 October 2013
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 454 (2) , 668-677
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Pyrazinamide Polymorphs: Relative Stability and Vibrational SpectroscopyCrystal Growth & Design, 2010
- A New Insight into Pyrazinamide Polymorphic Forms and their Thermodynamic RelationshipsCrystal Growth & Design, 2009
- Low Temperature Infrared Spectroscopy Study of Pyrazinamide: From the Isolated Monomer to the Stable Low Temperature Crystalline PhaseThe Journal of Physical Chemistry A, 2009
- Monitoring the buckling threshold of drying colloidal droplets using water-ethanol mixturesThe European Physical Journal E, 2008
- Pharmaceutical Particle Engineering via Spray DryingPharmaceutical Research, 2007
- Conformational Isomorphism of Organic Crystals: Racemic and Homochiral AtenololCrystal Growth & Design, 2007
- Aerosolised Antibacterials for the Prevention and Treatment of Hospital-Acquired PneumoniaDrugs, 2007
- Adjunctive Salvage Therapy with Inhaled Aminoglycosides for Patients with Persistent Smear-Positive Pulmonary TuberculosisClinical Infectious Diseases, 2001
- The action of antituberculosis drugs in short-course chemotherapyTubercle, 1985
- The crystal structure of α-pyrazinamideActa Crystallographica, 1960